Deciphex back home

Latest news

Patholytix Preclinical
September 2021

Experience Patholytix at the Cutting Edge Pathology Virtual Congress this Month

Deciphex are pleased to announce our Gold Sponsorship of the 4th ESVP, ECVP and ESTP Cutting Edge Pathology Congress taking place on the 15th-17th of September.

read more
Patholytix Preclinical
5 July 2021

Deciphex are delighted to announce the launch of Patholytix Preclinical 2.1

This latest release of our award winning digital pathology platform delivers significant workflow improvements for our users and provides even greater support for early stage research applications through the introduction of Quantitative Pathology.

read more
Patholytix Preclinical
6 May 2021

Deciphex Makes Key Appointments to Strengthen Team in Advance of Mid 2021 Clinical Market Entry

Deciphex, a leading provider of digital pathology and AI-powered services, announced that it has appointed Prof Runjan Chetty as Chief Medical Officer, Luke Benko as Vice President of Global Pathology Services and Chris Polley as Clinical Business Manager UK.

read more
Patholytix Preclinical
22 April 2021

Deciphex Led Consortium Secure €3m to Develop Novel Prognostic Tests to Avoid Overtreatment of Cancer Patients

Deciphex is pleased to announce its success, in collaboration with partners Oncomark and UCD, in securing a €3m Government of Ireland, Disruptive Technologies Innovation Fund award to pursue its ongoing research program in cancer prognostics.

read more
Patholytix Preclinical
28 January 2021

Deciphex Announces Membership of new EU IMI BIGPICTURE Project Consortium, Aiming to Build the World's Largest Image Collection for the Validation of AI Models in Clinical and Non Clinical Pathology

To take AI development in pathology to the next level, a European consortium combining leading European research centres, hospitals as well as major pharmaceutical industries, is going to develop a repository for the sharing of pathology data.

read more
Patholytix Preclinical
9 December 2020

Deciphex Delivers Industry-first Patholytix Digital Pathology Peer Review for GLP Studies in Partnership with Charles River Laboratories

Deciphex and Charles River Laboratories International, Inc. (NYSE: CRL) have jointly announced today that they are the first in the industry to offer clients Good Laboratory Practice (GLP) validated digital peer review, using Deciphex Patholytix Preclinical for toxicologic pathology.

read more
Patholytix Preclinical
12 October 2020

Deciphex launch Patholytix Preclinical 2.0 enabling GLP Digital Pathology Peer Review

At Deciphex our mission is to enable our users to facilitate digital peer review of non-clinical pathology studies. We are delighted to announce the upcoming launch of Patholytix Preclinical 2.0 which provides our clients with a pathway to a regulated GLP Peer Review in conjunction with their CRO partners.

read more
Patholytix Preclinical
10 September 2020

Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus

By combining Deciphex’s unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI.

read more
Patholytix Preclinical
18 August 2020

Deciphex are delighted to announce the launch of Patholytix AI 1.5

To mark the recent launch of Patholytix AI 1.5, we describe how Patholyix AI fits in the technology landscape available to AI developers working on Pathology AI projects, and how the platform can benefit them in accelerating impactful data generation for their pathology stakeholders.

read more
Patholytix Preclinical
9 July 2020

Deciphex Close $6.2m Series A Fundraising to Accelerate Commercialisation and Research Programs

Deciphex an Irish based technology player, developing ergonomic digital pathology workflows and AI for histopathology, has announced the conclusion of a $6.2m Series A fundraising which will empower the company to accelerate its research and development in Artificial Intelligence and to further accelerate market entry in preclincial/toxicologic digital pathology.

read more
Patholytix Preclinical
3 June 2020

Patholytix Preclinical 1.4 with Work from Home Mode

We understand that many of our partners now face changing work practices and are more reliant now than ever on remote collaborative tools to manage their day to day operations. Our team remains as committed and as capable as ever to supporting you, and to help you protect business continuity.

read more
Patholytix Preclinical
28 May 2020

Deciphex open US office in Chicago, Implement high throughput scanning service for clients.

Deciphex are delighted to announce the opening of its first US Facility as part of our planned US expansion.

read more
Patholytix Preclinical
30 March 2020

Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development with Digital Pathology

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a partnership with Deciphex, a leading company in the provisioning of global preclinical digital pathology services...

read more
Patholytix Preclinical
5 November 2019

Deciphex receives ISO 27001 certification

Deciphex, the leading global player in the provision of global preclinical digital pathology services, announced today that it has achieved certification against ISO 27001:2013, the premier global standard for Information Security Management Systems.

read more
Patholytix Preclinical
20 May 2019

Deciphex Applauded by Frost & Sullivan for its Machine Learning-powered Patholytix Preclinical Digital Pathology Platform

The Patholytix preclinical solution aids improved process efficiency in preclinical toxicology by adopting a unique pattern recognition approach.

read more
Patholytix Preclinical
15 April 2019

Deciphex Finalise 2.3m Equity Fundraising to Accelerate Commercialisation and Research Programs.

Deciphex an Irish based technology player, applying AI in pathology, has announced the conclusion of a €2.3m equity funding and convertible debt conversion event which will empower the company to accelerate its research and development in Artificial Intelligence and ramp up market entry in preclincial/toxicologic digital pathology.  

read more
Patholytix Preclinical
10 December 2018

Deciphex Successful in Securing €5.7m Disruptive Technologies Innovation Fund Award

Deciphex in conjunction with a number of high profile academic and industry collaborators have secured a significant grant to pursue the use of AI in colorectal cancer diagnostics and treatment.

read more
Patholytix Preclinical
15 November 2018

Deciphex featured in Irish Times

Bringing pathology into digital era to speed up disease diagnosis. Startup Deciphex uses a mix of artificial intelligence and computer-aided diagnostics
- Irish Times Article - 15th November 2018

read more
Patholytix Preclinical
8 November 2018

Deciphex Release Patholytix Preclinical

Deciphex are pleased to announce the release of their first commercial digital pathology product. Patholytix Preclinical is the first built for purpose digital pathology solution for preclinical/toxicologic pathology in pharma and clinical research organisations.  

read more
European Innovation Council Pilot
2 August 2018

Deciphex and GI Partners of Illinois Enter Strategic Alliance to Develop World’s Largest GI Pathology Content Database for Deep Learning.

Deciphex and GI Partners of Illinois, LLC (a large merger of several gastroenterology practices in Illinois) have established a strategic alliance to co-develop the world’s largest database of annotated, gastrointestinal (GI), digital pathology content for deep learning purposes.

read more
European Innovation Council Pilot
24 May 2018

Deciphex Awarded €2m from EU Fast Track to Innovation Program to Accelerate Development of AI Driven Workflows for Preclinical Pathology.

Deciphex in conjunction with commercial partners, Janssen Pharmaceuticals and PDS, has been awarded €2m from the EU Horizon2020, Fast Track to Innovation program, to accelerate development of artificial-intelligence based workflows for preclinical pathology.

read more
27 November 2017

Deciphex has filed two provisional patent applications directed to the field of abnormality detection.

Deciphex has established priority filing dates in the US on two inventions we believe will be critical to the future of Deep Learning in Pathology.

read more
31 October 2017

Pathology AI company, Deciphex closes first funding round, signs two collaboration agreements.

Deciphex is delighted to announce the closing of its first financing with support from key players in the Irish diagnostics industry.

read more
16 October 2017

Deciphex Selected for the EU SME Instrument Phase 1 Grant.

Deciphex is delighted to announce its successful awarding of an SME Instrument Phase 1 grant from the EU

read more

Contact Details

Deciphex INC

USA

Deciphex Inc.
1012 95th Street, Naperville,
Chicago, Illinois

Call: +1 630 581 0355

Email: andrew.fink@deciphex.com

send email
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
Copyright Deciphex 2020